Search research articles
Contact Us
Filters
Showing results (101-110 of 141) with videos related to
Page
of 15
Sort By:
Epilepsy Research and Treatment
|
March 15, 2014
Epilepsy surgery series: a study of 502 consecutive patients from a developing country
Abdulaziz Alsemari, Faisal Al-Otaibi, Salah Baz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 28, 2019
First-Line Treatment of Patients With Indolent Non-Hodgkin Lymphoma or Mantle-Cell Lymphoma With Bendamustine Plus Rituximab Versus R-CHOP or R-CVP: Results of the BRIGHT 5-Year Follow-Up Study
Ian W Flinn, Richard van der Jagt, Brad Kahl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 4, 2011
Bortezomib ADDED to R-CVP is safe and effective for previously untreated advanced-stage follicular lymphoma: a phase II study by the National Cancer Institute of Canada Clinical Trials Group
Laurie H Sehn, David MacDonald, Sheldon Rubin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 12, 2021
Single-Agent Ibrutinib for Rituximab-Refractory Waldenström Macroglobulinemia: Final Analysis of the Substudy of the Phase III Innovate<sup>TM</sup> Trial
Judith Trotman, Christian Buske, Alessandra Tedeschi, et al.
Frontiers in Neuroinformatics
|
August 27, 2016
MINC 2.0: A Flexible Format for Multi-Modal Images
Robert D Vincent, Peter Neelin, Najmeh Khalili-Mahani, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
February 16, 2016
Differences in Quality of Life Between Bendamustine-Rituximab and R-CHOP/R-CVP in Patients With Previously Untreated Advanced Indolent Non-Hodgkin Lymphoma or Mantle Cell Lymphoma
John M Burke, Richard H C van der Jagt, Brad S Kahl, et al.
British Journal of Anaesthesia
|
August 12, 2020
Frailty and long-term postoperative disability trajectories: a prospective multicentre cohort study
Daniel I McIsaac, Monica Taljaard, Gregory L Bryson, et al.
Annals of Surgery
|
July 27, 2018
Frailty as a Predictor of Death or New Disability After Surgery: A Prospective Cohort Study
Daniel I McIsaac, Monica Taljaard, Gregory L Bryson, et al.
Leukemia & Lymphoma
|
October 11, 2018
A phase I study of romidepsin, gemcitabine, dexamethasone and cisplatin combination therapy in the treatment of peripheral T-cell and diffuse large B-cell lymphoma; the Canadian cancer trials group LY.15 study†
Tony Reiman, Kerry J Savage, Michael Crump, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 7, 2017
The Senior Toronto Oncology Panel (STOP) Study: Research Participation for Older Adults With Cancer and Caregivers
Martine T E Puts, Schroder Sattar, Takami Fossat, et al.
Page
of 15
Search research articles
Search
Showing results (101-110 of 141) with videos related to
Sort By:
Page
of 15
Epilepsy Research and Treatment
|
March 15, 2014
Epilepsy surgery series: a study of 502 consecutive patients from a developing country
Abdulaziz Alsemari, Faisal Al-Otaibi, Salah Baz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 28, 2019
First-Line Treatment of Patients With Indolent Non-Hodgkin Lymphoma or Mantle-Cell Lymphoma With Bendamustine Plus Rituximab Versus R-CHOP or R-CVP: Results of the BRIGHT 5-Year Follow-Up Study
Ian W Flinn, Richard van der Jagt, Brad Kahl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 4, 2011
Bortezomib ADDED to R-CVP is safe and effective for previously untreated advanced-stage follicular lymphoma: a phase II study by the National Cancer Institute of Canada Clinical Trials Group
Laurie H Sehn, David MacDonald, Sheldon Rubin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 12, 2021
Single-Agent Ibrutinib for Rituximab-Refractory Waldenström Macroglobulinemia: Final Analysis of the Substudy of the Phase III Innovate<sup>TM</sup> Trial
Judith Trotman, Christian Buske, Alessandra Tedeschi, et al.
Frontiers in Neuroinformatics
|
August 27, 2016
MINC 2.0: A Flexible Format for Multi-Modal Images
Robert D Vincent, Peter Neelin, Najmeh Khalili-Mahani, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
February 16, 2016
Differences in Quality of Life Between Bendamustine-Rituximab and R-CHOP/R-CVP in Patients With Previously Untreated Advanced Indolent Non-Hodgkin Lymphoma or Mantle Cell Lymphoma
John M Burke, Richard H C van der Jagt, Brad S Kahl, et al.
British Journal of Anaesthesia
|
August 12, 2020
Frailty and long-term postoperative disability trajectories: a prospective multicentre cohort study
Daniel I McIsaac, Monica Taljaard, Gregory L Bryson, et al.
Annals of Surgery
|
July 27, 2018
Frailty as a Predictor of Death or New Disability After Surgery: A Prospective Cohort Study
Daniel I McIsaac, Monica Taljaard, Gregory L Bryson, et al.
Leukemia & Lymphoma
|
October 11, 2018
A phase I study of romidepsin, gemcitabine, dexamethasone and cisplatin combination therapy in the treatment of peripheral T-cell and diffuse large B-cell lymphoma; the Canadian cancer trials group LY.15 study†
Tony Reiman, Kerry J Savage, Michael Crump, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 7, 2017
The Senior Toronto Oncology Panel (STOP) Study: Research Participation for Older Adults With Cancer and Caregivers
Martine T E Puts, Schroder Sattar, Takami Fossat, et al.
Page
of 15